Pfizer 

C$10.28
29965
+C$0.17+1.68% Wednesday 19:33

Statistics

Day High
10.28
Day Low
10.28
52W High
10.28
52W Low
9.99
Volume
1,000
Avg. Volume
37
Mkt Cap
58.45B
P/E Ratio
-
Dividend Yield
6.66%
Dividend
0.68

Upcoming

Earnings

9FebExpected
Q3 2025
Next
0.56
0.59
0.63
0.67
Expected EPS
0.55521975825
Actual EPS
N/A

Financials

12.52%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
179.29BRevenue
22.45BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ZPFE.NEO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Show more...
CEO
Dr. Albert Bourla D.V.M., DVM, Ph.D.
Employees
79000
Country
US
ISIN
CA7169691002

Listings

0 Comments

Share your thoughts

FAQ

What is Pfizer stock price today?
The current price of ZPFE.NEO is C$10.28 CAD — it has increased by +1.68% in the past 24 hours. Watch Pfizer stock price performance more closely on the chart.
What is Pfizer stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pfizer stocks are traded under the ticker ZPFE.NEO.
What is Pfizer market cap?
Today Pfizer has the market capitalization of 58.45B
When is the next Pfizer earnings date?
Pfizer is going to release the next earnings report on February 09, 2026.
What were Pfizer earnings last quarter?
ZPFE.NEO earnings for the last quarter are 0.65 CAD per share, whereas the estimation was 0.67 CAD resulting in a -3.05% surprise. The estimated earnings for the next quarter are N/A CAD per share.
What is Pfizer revenue for the last year?
Pfizer revenue for the last year amounts to 179.29B CAD.
What is Pfizer net income for the last year?
ZPFE.NEO net income for the last year is 22.45B CAD.
How many employees does Pfizer have?
As of February 02, 2026, the company has 79,000 employees.
In which sector is Pfizer located?
Pfizer operates in the Healthcare sector.
When did Pfizer complete a stock split?
Pfizer has not had any recent stock splits.
Where is Pfizer headquartered?
Pfizer is headquartered in New York, US.